BCR and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a myeloproliferative neoplasm driven by the BCR::ABL1 (breakpoint cluster region-AbLeson fusion gene) fusion tyrosine kinase, whereas CLL is a lymphoproliferative disorder of monoclonal CD5+ve B lymphocytes.